Gould Robert J 4
4 · Fulcrum Therapeutics, Inc. · Filed Jan 13, 2023
Insider Transaction Report
Form 4
Gould Robert J
Director
Transactions
- Sale
Common Stock
2023-01-13$15.00/sh−6,766$101,490→ 499,864 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 7, 2022.